Cynthia E. Keen[email protected]Radiation Oncology/TherapyJAMA paper reignites debate over APBI treatmentThe debate over the effectiveness of breast cancer treatment with accelerated partial-breast irradiation (APBI) brachytherapy has resurfaced with the publication of a paper critical of the technology in the May 1 issue of the Journal of the American Medical Association.April 30, 2012Radiation Oncology/TherapyChemo with RT best for muscle-invasive bladder cancerThe combined treatment of chemotherapy and radiation therapy (RT) is more effective than radiation therapy alone for patients with muscle-invasive bladder cancer who don't have a cystectomy, according to a study to be published in the April 19 issue of the New England Journal of Medicine.April 17, 2012Radiation Oncology/TherapyIMRT seems most effective radiation therapy for prostate cancerThe use of intensity-modulated radiation therapy (IMRT) for prostate cancer caused fewer toxicities and less cancer recurrence than conformal radiotherapy and proton therapy treatments, according to a study published in the April 18 issue of the Journal of the American Medical Association.April 16, 2012Radiation Oncology/TherapyASBD: Toxicity of strut-based breast brachytherapy is lowBreast cancer patients who have accelerated partial-breast irradiation performed with a strut-based applicator experienced low toxicities from the treatment, according to a presentation at the annual symposium of the American Society of Breast Disease (ASBD).April 12, 2012ISDeadline looms for comment on stage 2 MU proposalsWhat is happening with the proposed stage 2 meaningful use (MU) requirements? Not much has been said since the flurry of media coverage accompanied a preview of the new requirements by Dr. Farzad Mostashari, the U.S. national coordinator for health IT, at HIMSS in February. But now is the time to speak up.April 12, 2012Radiation Oncology/TherapyStudy: IMRT for prostate cancer may be overusedA study published in the April issue of Health Affairs comparing two types of effective radiotherapy treatments for prostate cancer found that intensity-modulated radiation therapy (IMRT), the more expensive of the two, may be overused.April 11, 2012ISAuntMinnie.com Healthcare IT InsiderApril 9, 2012Radiation Oncology/TherapyGa. radiation therapy practice to settle $3.8M fraud claimThe U.S. Department of Justice has announced that a radiation oncology practice in Georgia has agreed to pay $3.8 million to settle allegations that it violated the False Claims Act by allegedly overbilling for claims submitted to Medicare.April 4, 2012Radiation Oncology/TherapyRadiotherapy complicates implant-based breast reconstructionRadiation therapy for the treatment of breast cancer significantly increases the incidence of major complications for women having implant-based breast reconstruction, according to new research published in the April issue of Plastic and Reconstructive Surgery.April 3, 2012Radiation Oncology/TherapyACR updates EBRT treatment planning for prostate cancerThe American College of Radiology (ACR) has published a summary of its updated evidence-based guidelines for external-beam radiation therapy (EBRT) treatment planning for clinically localized prostate cancer in the April issue of the Journal of the American College of Radiology.April 3, 2012Previous PagePage 19 of 88Next PageTop StoriesMolecular ImagingCase report: Pluvicto as a first-line treatment in late-stage prostate cancerSince 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.MRINew brain MRI imaging technique could help identify Alzheimer'sRadiology EducationScholarly activity low among residency program directorsDigital X-Ray3D DEXA shows value in patients with prostate cancerSponsor ContentDigital Innovations Shaping the Future of Radiology
